251 related articles for article (PubMed ID: 31512231)
1. Exosome DNA: Critical regulator of tumor immunity and a diagnostic biomarker.
Sharma A; Johnson A
J Cell Physiol; 2020 Mar; 235(3):1921-1932. PubMed ID: 31512231
[TBL] [Abstract][Full Text] [Related]
2. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer.
Bernard V; Kim DU; San Lucas FA; Castillo J; Allenson K; Mulu FC; Stephens BM; Huang J; Semaan A; Guerrero PA; Kamyabi N; Zhao J; Hurd MW; Koay EJ; Taniguchi CM; Herman JM; Javle M; Wolff R; Katz M; Varadhachary G; Maitra A; Alvarez HA
Gastroenterology; 2019 Jan; 156(1):108-118.e4. PubMed ID: 30240661
[TBL] [Abstract][Full Text] [Related]
3. The Biological Function and Therapeutic Potential of Exosomes in Cancer: Exosomes as Efficient Nanocommunicators for Cancer Therapy.
Choi JU; Park IK; Lee YK; Hwang SR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33028046
[TBL] [Abstract][Full Text] [Related]
4. Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of Bladder.
Lee DH; Yoon H; Park S; Kim JS; Ahn YH; Kwon K; Lee D; Kim KH
Sci Rep; 2018 Oct; 8(1):14707. PubMed ID: 30279572
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive genomic and transcriptomic profiling of visceral cancers by next-generation sequencing of circulating exosomes.
San Lucas FA; Allenson K; Bernard V; Castillo J; Kim DU; Ellis K; Ehli EA; Davies GE; Petersen JL; Li D; Wolff R; Katz M; Varadhachary G; Wistuba I; Maitra A; Alvarez H
Ann Oncol; 2016 Apr; 27(4):635-41. PubMed ID: 26681674
[TBL] [Abstract][Full Text] [Related]
6. Beyond tumor mutational burden: potential and limitations in using exosomes to predict response to immunotherapy.
Crow J; Samuel G; Godwin AK
Expert Rev Mol Diagn; 2019 Dec; 19(12):1079-1088. PubMed ID: 31687863
[No Abstract] [Full Text] [Related]
7. Designer exosomes as next-generation cancer immunotherapy.
Bell BM; Kirk ID; Hiltbrunner S; Gabrielsson S; Bultema JJ
Nanomedicine; 2016 Jan; 12(1):163-9. PubMed ID: 26500074
[TBL] [Abstract][Full Text] [Related]
8. Exosomes for Non-Invasive Cancer Monitoring.
Kalishwaralal K; Kwon WY; Park KS
Biotechnol J; 2019 Jan; 14(1):e1800430. PubMed ID: 30358137
[TBL] [Abstract][Full Text] [Related]
9. REMEDIAL APPLICATIONS OF EXOSOMES IN CANCER, INFECTIONS AND DIABETES.
Wang Q; Ding X; Zhen F; Ma J; Meng F
Acta Pol Pharm; 2017 Mar; 74(2):313-320. PubMed ID: 29624236
[TBL] [Abstract][Full Text] [Related]
10. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
11. Unique somatic variants in DNA from urine exosomes of individuals with bladder cancer.
Zhou X; Kurywchak P; Wolf-Dennen K; Che SPY; Sulakhe D; D'Souza M; Xie B; Maltsev N; Gilliam TC; Wu CC; McAndrews KM; LeBleu VS; McConkey DJ; Volpert OV; Pretzsch SM; Czerniak BA; Dinney CP; Kalluri R
Mol Ther Methods Clin Dev; 2021 Sep; 22():360-376. PubMed ID: 34514028
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the exosome-induced immune response for cancer immunotherapy.
Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
[TBL] [Abstract][Full Text] [Related]
13. The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.
Whiteside TL
Expert Rev Mol Diagn; 2018 Dec; 18(12):1029-1040. PubMed ID: 30406709
[No Abstract] [Full Text] [Related]
14. Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA.
Morishita M; Takahashi Y; Matsumoto A; Nishikawa M; Takakura Y
Biomaterials; 2016 Dec; 111():55-65. PubMed ID: 27723556
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
Salehi M; Sharifi M
J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Derived Exosomes and Their Role in Cancer Progression.
Whiteside TL
Adv Clin Chem; 2016; 74():103-41. PubMed ID: 27117662
[TBL] [Abstract][Full Text] [Related]
17. Engineering Exosomes for Cancer Therapy.
Gilligan KE; Dwyer RM
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
[TBL] [Abstract][Full Text] [Related]
18. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment.
Sun Z; Yang S; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Xu J; Xia K; Chang Y; Liu J; Yuan W
Mol Cancer; 2018 Apr; 17(1):82. PubMed ID: 29678180
[TBL] [Abstract][Full Text] [Related]
20. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
Alfonsi R; Grassi L; Signore M; Bonci D
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
